Forecasts next-decade innovations—emerging modalities, automation, AI, and coordinated investment strategies that will shape a sustainable CGT ecosystem. The development of the cell and gene therapy (CGT) ecosystem depends on the bridge between public institutions, private investors, and industry stakeholders. At the Cell & Gene Therapy World 2026 Conference, leaders from government agencies, capital venture, biopharma, and research organizations will discuss how strategic partnerships and new finance models are advancing the CGT ecosystem.
Stem Cell Conference 2026 will feature pioneering research in regenerative medicine, stem cell therapy, and biotechnology advancements.